Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,541.39
(
0.04%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 122991

Thursday, 07/07/2011 6:04:49 PM

Thursday, July 07, 2011 6:04:49 PM

Post# of 257264

VRUS—my hunch is the FDA is not that open-minded...

Well, well...I was able to nudge you off the fence :- )

I’m inclined to agree—i.e. I do not expect VRUS to submit an NDA in genotype-2/3 based on only the phase-2 data. However, oc631 has called everything correctly in the HCV arena to date, and he thinks this might be doable; for this reason alone, we should not dismiss the idea out of hand.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up